Financials Cowealth Medical Holding Co., Ltd.

Equities

4745

KYG248111042

Advanced Medical Equipment & Technology

End-of-day quote Taipei Exchange 03:30:00 03/05/2024 am IST 5-day change 1st Jan Change
23.6 TWD +0.43% Intraday chart for Cowealth Medical Holding Co., Ltd. +1.29% -8.53%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,471 3,068 2,459 2,060 1,925 1,998
Enterprise Value (EV) 1 3,030 2,930 2,233 2,131 1,190 1,718
P/E ratio 8.87 x 11 x 19.8 x 14.8 x 20.5 x 35.9 x
Yield 0.75% 2.88% 3.78% 5.64% 6.44% 1.55%
Capitalization / Revenue 0.63 x 0.66 x 0.52 x 0.4 x 0.34 x 0.42 x
EV / Revenue 0.78 x 0.63 x 0.47 x 0.41 x 0.21 x 0.36 x
EV / EBITDA 6.68 x 6.02 x 5.2 x 5.47 x 2.93 x 5.56 x
EV / FCF -12.5 x -10.8 x 9.2 x -11.9 x -2.61 x -12.5 x
FCF Yield -8.01% -9.3% 10.9% -8.4% -38.3% -7.99%
Price to Book 1.35 x 1.26 x 0.97 x 0.8 x 0.68 x 0.73 x
Nbr of stocks (in thousands) 77,450 77,450 77,450 77,450 77,450 77,450
Reference price 2 31.90 39.62 31.75 26.60 24.85 25.80
Announcement Date 01/04/19 31/03/20 31/03/21 30/03/22 29/03/23 29/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3,899 4,665 4,722 5,140 5,626 4,813
EBITDA 1 453.8 486.9 429.2 389.9 405.5 309.1
EBIT 1 355.7 408.7 338 341 369.8 276.2
Operating Margin 9.12% 8.76% 7.16% 6.63% 6.57% 5.74%
Earnings before Tax (EBT) 1 505.9 396 314.9 334.7 388.3 270.3
Net income 1 286.2 279.8 124.4 139.5 94.12 55.71
Net margin 7.34% 6% 2.63% 2.71% 1.67% 1.16%
EPS 2 3.595 3.610 1.606 1.800 1.210 0.7193
Free Cash Flow 1 -242.6 -272.4 242.7 -179 -455.4 -137.3
FCF margin -6.22% -5.84% 5.14% -3.48% -8.09% -2.85%
FCF Conversion (EBITDA) - - 56.53% - - -
FCF Conversion (Net income) - - 195.07% - - -
Dividend per Share 2 0.2381 1.143 1.200 1.500 1.600 0.4000
Announcement Date 01/04/19 31/03/20 31/03/21 30/03/22 29/03/23 29/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2
Net sales 1 1,355 1,398
EBITDA - -
EBIT 1 78 114.7
Operating Margin 5.76% 8.2%
Earnings before Tax (EBT) - -
Net income - -
Net margin - -
EPS - -
Dividend per Share - -
Announcement Date 15/05/22 30/08/22
1TWD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 559 - - 70.7 - -
Net Cash position 1 - 139 226 - 735 280
Leverage (Debt/EBITDA) 1.232 x - - 0.1812 x - -
Free Cash Flow 1 -243 -272 243 -179 -455 -137
ROE (net income / shareholders' equity) 16.6% 12.9% 6.17% 6.21% 5.39% 2.94%
ROA (Net income/ Total Assets) 5.76% 5.37% 3.91% 3.95% 3.67% 2.49%
Assets 1 4,971 5,206 3,177 3,527 2,567 2,234
Book Value Per Share 2 23.60 31.60 32.90 33.20 36.60 35.10
Cash Flow per Share 2 8.370 16.60 15.60 10.90 17.90 10.80
Capex 1 59.9 89.2 27.4 34.5 18.7 206
Capex / Sales 1.54% 1.91% 0.58% 0.67% 0.33% 4.29%
Announcement Date 01/04/19 31/03/20 31/03/21 30/03/22 29/03/23 29/03/24
1TWD in Million2TWD
Estimates
  1. Stock Market
  2. Equities
  3. 4745 Stock
  4. Financials Cowealth Medical Holding Co., Ltd.